Arul P, Masilamani Suresh
Department of Pathology, Dhanalakshmi Srinivasan Medical College and Hospital, Siruvachur, Perambalur, Tamil Nadu, India.
J Cancer Res Ther. 2015 Jul-Sep;11(3):617-22. doi: 10.4103/0973-1482.157302.
Fine needle aspiration cytology (FNAC) is a useful diagnostic modality in the evaluation of solitary thyroid nodules (STN). It can differentiate between benign and malignant lesions in most cases.
This study was undertaken to determine the utility and diagnostic accuracy of FNAC in the evaluation of STN.
In this retrospective study, a total number of 483 thyroid FNACs were retrieved, out of which 209 cases of STN were chosen for this study. The Bethesda system for reporting thyroid cytopathology (TBSRTC) was used for analysis. Their FNACs diagnoses were compared with histopathological diagnoses.
Among 209 FNACs, 88 (42.1%) had non-neoplastic lesions, 6 (2.9%) had atypia of undetermined significance/follicular lesions of undetermined significance (AUS/FLUS), 52 (24.9%) had follicular neoplasm/suspicious for a follicular neoplasm (FN/SFN), 33 (15.8%) were suspicious for malignancy and 18 (8.6%) had malignant cytology. The sensitivity, specificity, accuracy, positive predictive value and negative predictive value of FNAC in STN cases were 94.4%, 97.6%, 95.8%, 98.1% and 93.2% respectively.
Our study concluded that FNAC reporting using TBSRTC highly correlated with the histopathological diagnosis and our results were comparable with published data. The FNAC diagnosis helps in triaging patients with STN and identifies those who require surgical intervention. It is a simple, convenient, cost effective, sensitive, specific, safe and accurate initial diagnostic method for the preoperative evaluation of STN.
细针穿刺细胞学检查(FNAC)是评估甲状腺单发结节(STN)的一种有用的诊断方法。在大多数情况下,它可以区分良性和恶性病变。
本研究旨在确定FNAC在评估STN中的实用性和诊断准确性。
在这项回顾性研究中,共检索到483例甲状腺FNAC病例,其中209例STN病例被选入本研究。采用甲状腺细胞病理学报告的贝塞斯达系统(TBSRTC)进行分析。将其FNAC诊断结果与组织病理学诊断结果进行比较。
在209例FNAC病例中,88例(42.1%)为非肿瘤性病变,6例(2.9%)为意义不明确的非典型病变/意义不明确的滤泡性病变(AUS/FLUS),52例(24.9%)为滤泡性肿瘤/可疑滤泡性肿瘤(FN/SFN),33例(15.8%)为可疑恶性,18例(8.6%)为恶性细胞学。STN病例中FNAC的敏感性、特异性、准确性、阳性预测值和阴性预测值分别为94.4%、97.6%、95.8%、98.1%和93.2%。
我们研究得出结论,使用TBSRTC进行FNAC报告与组织病理学诊断高度相关,我们的结果与已发表的数据相当。FNAC诊断有助于对STN患者进行分类,并识别那些需要手术干预的患者。它是一种简单、方便、经济有效、敏感、特异、安全且准确的用于STN术前评估的初始诊断方法。